T-CELL LYMPHOMA

Clinical trials for T-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new T-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 1 Completed 4 Terminated 2

New drug combo targets tough T-Cell lymphoma

Disease control Terminated

This early-phase trial tests whether combining two existing drugs, azacitidine and abatacept, can shrink tumors in adults with T-cell lymphoma that has relapsed or not responded to prior therapy. About 20 participants will receive the drugs in 28-day cycles for up to 13 cycles. T…

Matched conditions: T-CELL LYMPHOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 17, 2026 06:44 UTC

T-CELL LYMPHOMA

Get alerted when new T-CELL LYMPHOMA trials appear

New drug combo targets tough T-Cell lymphoma